Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Q Eichacker

Showing results (51-60 of 122) with videos related to

Pageof 13
Sort By:
The American Journal of the Medical Sciences|October 16, 2004
Recombinant human activated protein C in sepsis: assessing its clinical useMichael Haley, Xizhong Cui, Peter C Minneci, et al.
Current Opinion in Infectious Diseases|May 29, 2004
Activated protein C in sepsis: emerging insights regarding its mechanism of action and clinical effectivenessMichael Haley, Xizhong Cui, Peter C Minneci, et al.
Critical Care Medicine|March 26, 2009
Antithrombosis Trials: Should we test therapeutic heparin adjusted based on activated partial thromboplastin time in septic shock?Amisha V Barochia, Yan Li, Xizhong Cui, et al.
Critical Care (London, England)|June 17, 2016
Increased body mass index and adjusted mortality in ICU patients with sepsis or septic shock: a systematic review and meta-analysisDominique J Pepper, Junfeng Sun, Judith Welsh, et al.
Critical Care Medicine|April 26, 2020
Individualized Care Is Superior to Standardized Care for the Majority of Critically Ill PatientsIrene Cortés-Puch, Willard N Applefeld, Jeffrey Wang, et al.
Critical Care Medicine|January 21, 2006
Antithrombotic therapies for sepsis: a need for more studiesPeter C Minneci, Katherine J Deans, Xizhong Cui, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|May 12, 2020
Comparative effectiveness research in critically ill patients: risks associated with mischaracterising usual careWillard N Applefeld, Jeffrey Wang, Harvey G Klein, et al.
Critical Care Medicine|May 14, 2005
Mechanical ventilation in ARDS: One size does not fit allKatherine J Deans, Peter C Minneci, Xizhong Cui, et al.
Journal of Thoracic Disease|March 10, 2020
Driving blind: instituting SEP-1 without high quality outcomes dataJeffrey Wang, Jeffrey R Strich, Willard N Applefeld, et al.
Intensive Care Medicine|January 25, 2008
The importance of usual care control groups for safety monitoring and validity during critical care researchPeter C Minneci, Peter Q Eichacker, Robert L Danner, et al.
Pageof 13

Showing results (51-60 of 122) with videos related to

Sort By:
Pageof 13
The American Journal of the Medical Sciences|October 16, 2004
Recombinant human activated protein C in sepsis: assessing its clinical useMichael Haley, Xizhong Cui, Peter C Minneci, et al.
Current Opinion in Infectious Diseases|May 29, 2004
Activated protein C in sepsis: emerging insights regarding its mechanism of action and clinical effectivenessMichael Haley, Xizhong Cui, Peter C Minneci, et al.
Critical Care Medicine|March 26, 2009
Antithrombosis Trials: Should we test therapeutic heparin adjusted based on activated partial thromboplastin time in septic shock?Amisha V Barochia, Yan Li, Xizhong Cui, et al.
Critical Care (London, England)|June 17, 2016
Increased body mass index and adjusted mortality in ICU patients with sepsis or septic shock: a systematic review and meta-analysisDominique J Pepper, Junfeng Sun, Judith Welsh, et al.
Critical Care Medicine|April 26, 2020
Individualized Care Is Superior to Standardized Care for the Majority of Critically Ill PatientsIrene Cortés-Puch, Willard N Applefeld, Jeffrey Wang, et al.
Critical Care Medicine|January 21, 2006
Antithrombotic therapies for sepsis: a need for more studiesPeter C Minneci, Katherine J Deans, Xizhong Cui, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|May 12, 2020
Comparative effectiveness research in critically ill patients: risks associated with mischaracterising usual careWillard N Applefeld, Jeffrey Wang, Harvey G Klein, et al.
Critical Care Medicine|May 14, 2005
Mechanical ventilation in ARDS: One size does not fit allKatherine J Deans, Peter C Minneci, Xizhong Cui, et al.
Journal of Thoracic Disease|March 10, 2020
Driving blind: instituting SEP-1 without high quality outcomes dataJeffrey Wang, Jeffrey R Strich, Willard N Applefeld, et al.
Intensive Care Medicine|January 25, 2008
The importance of usual care control groups for safety monitoring and validity during critical care researchPeter C Minneci, Peter Q Eichacker, Robert L Danner, et al.
Pageof 13